Andorfer, C. et al. (2003) “Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms,” Journal of Neurochemistry, 86(3), pp. 582–590. doi: 10.1046/j.1471-4159.2003.01879.x.
Andreone, B. J. et al. (2017) “Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis,” Neuron, 94(3), pp. 581-594.e5. doi: 10.1016/j.neuron.2017.03.043.
Bachmeier, C. et al. (2014) “Apolipoprotein E Isoform-Specific Effects on Lipoprotein Receptor Processing,” NeuroMolecular Medicine, 16(4), pp. 686–696. doi: 10.1007/s12017-014-8318-6.
Bachmeier, C., Mullan, M. and Paris, D. (2010) “Characterization and use of human brain microvascular endothelial cells to examine β-amyloid exchange in the blood-brain barrier,” Cytotechnology, 62(6), pp. 519–529. doi: 10.1007/s10616-010-9313-x.
Badaut, J. et al. (2015) “Caveolin expression changes in the neurovascular unit after juvenile traumatic brain injury: Signs of blood-brain barrier healing?,” Neuroscience, 285, pp. 215–226. doi: 10.1016/j.neuroscience.2014.10.035.
Banks, W. A. (2015) “The blood-brain barrier in neuroimmunology: Tales of separation and assimilation,” Brain, Behavior, and Immunity, 44, pp. 1–8. doi: 10.1016/j.bbi.2014.08.007.
Banks, W. A. et al. (2016) “Tau proteins cross the blood-brain barrier,” Journal of Alzheimer’s Disease, 55(1), pp. 411–419. doi: 10.3233/JAD-160542.
Ben-Zvi, A. et al. (2014) “Mfsd2a is critical for the formation and function of the blood-brain barrier,” Nature, 509(7501), pp. 507–511. doi: 10.1038/nature13324.
Bonds, J. A. et al. (2019) “Depletion of Caveolin-1 in Type 2 Diabetes Model Induces Alzheimer’s Disease Pathology Precursors,” The Journal of neuroscience : the official journal of the Society for Neuroscience, 39(43), pp. 8576–8583. doi: 10.1523/JNEUROSCI.0730-19.2019.
Brickler, T. R. et al. (2018) “Angiopoietin/tie2 axis regulates the age-at-injury cerebrovascular response to traumatic brain injury,” Journal of Neuroscience, 38(45), pp. 9618–9634. doi: 10.1523/JNEUROSCI.0914-18.2018.
Clavaguera, F. et al. (2009) “Transmission and spreading of tauopathy in transgenic mouse brain,” Nature Cell Biology, 11(7), pp. 909–913. doi: 10.1038/ncb1901.
David, D. C. et al. (2002) “Proteasomal degradation of tau protein,” Journal of Neurochemistry, 83(1), pp. 176–185. doi: 10.1046/j.1471-4159.2002.01137.x.
Deane, R. et al. (2009) “Endothelial protein C receptor-assisted transport of activated protein C across the mouse blood-brain barrier,” Journal of Cerebral Blood Flow and Metabolism, 29(1), pp. 25–33. doi: 10.1038/jcbfm.2008.117.
Dolan, P. J. and Johnson, G. V. W. (2010) “A caspase cleaved form of tau is preferentially degraded through the autophagy pathway,” Journal of Biological Chemistry, 285(29), pp. 21978–21987. doi: 10.1074/jbc.M110.110940.
Dore-Duffy, P. et al. (2007) “Differential expression of capillary VEGF isoforms following traumatic brain injury,” Neurological Research, 29(4), pp. 395–403. doi: 10.1179/016164107X204729.
Engelhardt, B. and Liebner, S. (2014) “Novel insights into the development and maintenance of the blood-brain barrier,” Cell and Tissue Research. Springer Verlag, pp. 687–699. doi: 10.1007/s00441-014-1811-2.
Eser Ocak, P., Ocak, U., Sherchan, P., Zhang, J. H., et al. (2020) “Insights into major facilitator superfamily domain-containing protein-2a (Mfsd2a) in physiology and pathophysiology. What do we know so far?,” Journal of Neuroscience Research. John Wiley and Sons Inc., pp. 29–41. doi: 10.1002/jnr.24327.
Eser Ocak, P., Ocak, U., Sherchan, P., Gamdzyk, M., et al. (2020) “Overexpression of Mfsd2a attenuates blood brain barrier dysfunction via Cav-1/Keap-1/Nrf-2/HO-1 pathway in a rat model of surgical brain injury,” Experimental Neurology, 326. doi: 10.1016/j.expneurol.2020.113203.
Evans, L. D. et al. (2018) “Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct Pathways,” Cell Reports, 22(13), pp. 3612–3624. doi: 10.1016/j.celrep.2018.03.021.
Felcht, M. et al. (2012) “Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling,” Journal of Clinical Investigation, 122(6), pp. 1991–2005. doi: 10.1172/JCI58832.
Frost, B., Jacks, R. L. and Diamond, M. I. (2009) “Propagation of Tau misfolding from the outside to the inside of a cell,” Journal of Biological Chemistry, 284(19), pp. 12845–12852. doi: 10.1074/jbc.M808759200.
Gaengel, K. et al. (2009) “Endothelial-mural cell signaling in vascular development and angiogenesis,” Arteriosclerosis, Thrombosis, and Vascular Biology, pp. 630–638. doi: 10.1161/ATVBAHA.107.161521.
Gill, J. et al. (2017) “Acute plasma tau relates to prolonged return to play after concussion,” Neurology, 88(6), pp. 595–602. doi: 10.1212/WNL.0000000000003587.
Gong, D. et al. (2011) “Dynamic changes of vascular endothelial growth factor and angiopoietin-1 in association with circulating endothelial progenitor cells after severe traumatic brain injury,” Journal of Trauma - Injury, Infection and Critical Care, 70(6), pp. 1480–1484. doi: 10.1097/TA.0b013e31821ac9e1.
Gu, H. et al. (2016) “Angiopoietin-1 and angiopoietin-2 expression imbalance influence in early period after subarachnoid hemorrhage,” International Neurourology Journal, 20(4), pp. 288–295. doi: 10.5213/inj.1632692.346.
Hansen, T. M. et al. (2010) “Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface,” Cellular Signalling, 22(3), pp. 527–532. doi: 10.1016/j.cellsig.2009.11.007.
Head, B. P. et al. (2010) “Loss of caveolin-1 accelerates neurodegeneration and aging,” PLoS ONE, 5(12), pp. 1–13. doi: 10.1371/journal.pone.0015697.
Iliff, J. J. et al. (2014) “Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury,” Journal of Neuroscience, 34(49), pp. 16180–16193. doi: 10.1523/JNEUROSCI.3020-14.2014.
Jozic, I. et al. (2019) “Pharmacological and Genetic Inhibition of Caveolin-1 Promotes Epithelialization and Wound Closure,” Molecular Therapy, 27(11), pp. 1992–2004. doi: 10.1016/j.ymthe.2019.07.016.
Kim, I. et al. (2000) “Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway,” Circulation Research, 86(1), pp. 24–29. doi: 10.1161/01.RES.86.1.24.
Kurmann, L. et al. (2021) “Transcryptomic Analysis of Human Brain-Microvascular Barrier Function,” Cells, 10, pp. 1–23. doi: 10.3390/cells10040963.
Laksitorini, M. D. et al. (2019) “Modulation of Wnt/β-catenin signaling promotes blood-brain barrier phenotype in cultured brain endothelial cells,” Scientific Reports, 9(1), pp. 1–13. doi: 10.1038/s41598-019-56075-w.
Magnoni, S. et al. (2012) “Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injury,” Brain, 135(4), pp. 1268–1280. doi: 10.1093/brain/awr286.
Marklund, N. et al. (2009) “Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury: Clinical article,” Journal of Neurosurgery, 110(6), pp. 1227–1237. doi: 10.3171/2008.9.JNS08584.
McKee, A. C. et al. (2009) “Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury,” Journal of Neuropathology and Experimental Neurology, pp. 709–735. doi: 10.1097/NEN.0b013e3181a9d503.
McKee, A. C. et al. (2016) “The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy,” Acta Neuropathologica, 131(1), pp. 75–86. doi: 10.1007/s00401-015-1515-z.
Medina, M. and Avila, J. (2014) “The role of extracellular Tau in the spreading of neurofibrillary pathology,” Frontiers in Cellular Neuroscience. Frontiers Research Foundation. doi: 10.3389/fncel.2014.00113.
Mirbaha, H. et al. (2017) “Inert and seed-competent tau monomers suggest structural origins of aggregation,” bioRxiv, pp. 1–29. doi: 10.1101/163394.
Mouzon, B. et al. (2012) “Repetitive mild traumatic brain injury in a mouse model produces learning and memory deficits accompanied by histological changes,” Journal of Neurotrauma, 29(18), pp. 2761–2773. doi: 10.1089/neu.2012.2498.
Mouzon, B. C. et al. (2014) “Chronic neuropathological and neurobehavioral changes in a repetitive mild traumatic brain injury model,” Annals of Neurology, 75(2), pp. 241–254. doi: 10.1002/ana.24064.
Nag, S. et al. (2017) “Molecular Changes Associated with the Protective Effects of Angiopoietin-1 During Blood-Brain Barrier Breakdown Post-Injury,” Molecular Neurobiology, 54(6), pp. 4232–4242. doi: 10.1007/s12035-016-9973-4.
Natarajan, R., Northrop, N. and Yamamoto, B. (2017) “Fluorescein isothiocyanate (FITC)-dextran extravasation as a measure of blood-brain barrier permeability,” Current Protocols in Neuroscience, 2017, pp. 9.58.1-9.58.15. doi: 10.1002/cpns.25.
Nimmo, J. et al. (2020) “Peri-arterial pathways for clearance of α-Synuclein and tau from the brain: Implications for the pathogenesis of dementias and for immunotherapy,” Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring, 12(1), pp. 1–10. doi: 10.1002/dad2.12070.
Nourhaghighi, N. et al. (2003) “Altered expression of angiopoietins during blood-brain barrier breakdown and angiogenesis,” Laboratory Investigation, 83(8), pp. 1211–1222. doi: 10.1097/01.LAB.0000082383.40635.FE.
Ojo, J. et al. (2021) “Mural cell dysfunction leads to altered cerebrovascular tau uptake following repetitive head trauma,” Neurobiology of Disease, 150(December 2020), p. 105237. doi: 10.1016/j.nbd.2020.105237.
Öst, M. et al. (2006) “Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury,” Neurology, 67(9), pp. 1600–1604. doi: 10.1212/01.wnl.0000242732.06714.0f.
Paris, D. et al. (2011) “Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier,” Molecular Medicine, 17(3–4), pp. 149–162. doi: 10.2119/molmed.2010.00180.
Park, Y. S. et al. (2016) “Expression of angiopoietin-1 in hypoxic pericytes: Regulation by hypoxia-inducible factor-2α and participation in endothelial cell migration and tube formation,” Biochemical and Biophysical Research Communications, 469(2), pp. 263–269. doi: 10.1016/j.bbrc.2015.11.108.
Potje, S. R. et al. (2019) “Reduced caveolae density in arteries of SHR contributes to endothelial dysfunction and ROS production,” Scientific Reports, 9(1). doi: 10.1038/s41598-019-43193-8.
Sabirzhanov, B. et al. (2018) “MicroRNA-711-Induced Downregulation of Angiopoietin-1 Mediates Neuronal Cell Death,” Journal of Neurotrauma, 35(20), pp. 2462–2481. doi: 10.1089/neu.2017.5572.
Salehi, A., Zhang, J. H. and Obenaus, A. (2017) “Response of the cerebral vasculature following traumatic brain injury,” Journal of Cerebral Blood Flow and Metabolism. SAGE Publications Ltd, pp. 2320–2339. doi: 10.1177/0271678X17701460.
Sato, C. et al. (2018) “Tau Kinetics in Neurons and the Human Central Nervous System,” Neuron, 97(6), pp. 1284-1298.e7. doi: 10.1016/j.neuron.2018.02.015.
Sui, Y. T. et al. (2014) “Alpha synuclein is transported into and out of the brain by the blood-brain barrier,” Peptides, 62, pp. 197–202. doi: 10.1016/j.peptides.2014.09.018.
Sun, Zhengyu. et al. (2021) “Reduction of Pericyte Coverage Leads to Blood- Brain Barrier Dysfunction Via Endothelial Transcytosis Following Chronic Cerebral Hypoperfusion,” Fluids and Barriers of the CNS, 18(21), pp. 1–18. doi: 10.1186/s12987-021-00255-2.
Sundberg, C. et al. (2002) “Stable expression of angiopoietin-1 and other markers by cultured pericytes: Phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo,” Laboratory Investigation, 82(4), pp. 387–401. doi: 10.1038/labinvest.3780433.
Sweeney, M. D., Ayyadurai, S. and Zlokovic, B. v. (2016) “Pericytes of the neurovascular unit: Key functions and signaling pathways,” Nature Neuroscience. Nature Publishing Group, pp. 771–783. doi: 10.1038/nn.4288.
Tian, X. et al. (2020) “On the shuttling across the blood-brain barrier via tubules formation: Mechanism and cargo avidity bias,” bioRxiv, (November), pp. 1–16. doi: 10.1101/2020.04.04.025866.
Wang, J. et al. (2018) “Physiological clearance of tau in the periphery and its therapeutic potential for tauopathies,” Acta Neuropathologica, 136(4), pp. 525–536. doi: 10.1007/s00401-018-1891-2.
Wang, Z. et al. (2020) Wnt signaling activates MFSD2A to suppress vascular endothelial transcytosis and maintain blood-retinal barrier, Sci. Adv. Available at: http://advances.sciencemag.org/.
Wu, J. W. et al. (2013) “Small misfolded tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons,” Journal of Biological Chemistry, 288(3), pp. 1856–1870. doi: 10.1074/jbc.M112.394528.
Yamada, K. et al. (2011) “In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice,” Journal of Neuroscience, 31(37), pp. 13110–13117. doi: 10.1523/JNEUROSCI.2569-11.2011.
Yamada, K. et al. (2015) “Analysis of in vivo turnover of tau in a mouse model of tauopathy,” Molecular Neurodegeneration, 10(1). doi: 10.1186/s13024-015-0052-5.
Yanamandra, K. et al. (2017) “Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy,” Science Translational Medicine, 9(386). doi: 10.1126/scitranslmed.aal2029.
Yang, A. C. et al. (2020) “Physiological blood–brain transport is impaired with age by a shift in transcytosis,” Nature, 583(7816), pp. 425–430. doi: 10.1038/s41586-020-2453-z.
Yang, Y. R. et al. (2017) “Mfsd2a (major facilitator superfamily domain containing 2a) attenuates intracerebral hemorrhage-induced blood-brain barrier disruption by inhibiting vesicular transcytosis,” Journal of the American Heart Association, 6(7). doi: 10.1161/JAHA.117.005811.
Zhang, J. et al. (2011) “Angiopoietin-1/Tie2 signal augments basal notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of β-catenin,” Journal of Biological Chemistry, 286(10), pp. 8055–8066. doi: 10.1074/jbc.M110.192641.
Zhao, C. et al. (2020) “Mfsd2a Attenuates Blood-Brain Barrier Disruption After Sub-arachnoid Hemorrhage by Inhibiting Caveolae-Mediated Transcellular Transport in Rats,” Translational Stroke Research, 11(5), pp. 1012–1027. doi: 10.1007/s12975-019-00775-y.